Patients with advanced Merkel cell carcinoma had significant increases in survival rates following FDA approval of immune checkpoint inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback